BBlogFlow

Study Shows Meat Eaters Are More Likely to Survive to 100, But There's a Catch - ScienceAlert

·3d ago
Source: ScienceAlert
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Humans are living longer than ever before. By 2050, scientists predict that nearly half a billion people could be older than 80. The rise in human life expectancy is partly due to improvements in nutrition, but which food choices lead to the longest and healthiest outcomes in older age? Scientists are still trying to figure that out. In younger cohorts, some particular diets are associated with years of added life, especially those focused on whole, plant-based foods and healthy fats. But meat choices are more controversial, and they typically come with a catch. A study from China has now added another wrinkle to the research. Among more than 5,000 people aged 80 and over, researchers found that female meat eaters were more likely to reach age 100 than female vegetarians. There was no significant association between longevity and vegetarianism among males when the researchers analyzed the data by sex. Before you go sending this article to every female vegetarian you know, you should stay for the nuance. It was only vegetarian participants deemed underweight who were less likely to live to 100 than meat eaters.

This article is an excerpt. To read the full content, visit the original source. ScienceAlert

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·